Top

Published in:

01-12-2021 | Kidney Cancer | Commentary

Advancing the diagnosis and classification of renal cell carcinomas

Author: Joseph A. Rothwell

Published in: BMC Medicine | Issue 1/2021

Excerpt

Renal cancer is of concern due to its rising incidence worldwide, with new cases per year expected to climb by as much as 20% by 2030 [1]. Renal neoplasms encompass a variety of malignant and benign tumours with varying prognoses. Accurate classification and diagnosis currently rely on immunohistochemistry to detect known protein markers, in combination with examination of morphological characteristics. Accurate identifications are not always possible, which in turn hinders the delivery of a diagnosis and process to adapted treatment plans. Advanced-stage renal cell carcinomas carry extremely poor prognoses, so improved methods are urgently needed. …

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-a Cancer Journal for Clinicians. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.CrossRefPubMed

Wisniewski JR, Hein MY, Cox J, Mann M. A "proteomic ruler" for protein copy number and concentration estimation without spike-in standards. Mol Cell Proteomics. 2014;13(12):3497–506. https://doi.org/10.1074/mcp.M113.037309.CrossRefPubMedPubMedCentral

Wisniewski JR, Dus-Szachniewicz K, Ostasiewicz P, Ziolkowski P, Rakus D, Mann M. Absolute proteome analysis of colorectal mucosa, adenoma, and cancer reveals drastic changes in fatty acid metabolism and plasma membrane transporters. J Proteome Res. 2015;14(9):4005–18. https://doi.org/10.1021/acs.jproteome.5b00523.CrossRefPubMed

Jorge S, Capelo JL, LaFramboise W, Satturwar S, Korentzelos D, Bastacky S, et al. Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms. BMC Med. 2021. https://doi.org/10.1186/s12916-021-02071-9.

Clark DJ, Zhang H. Proteomic approaches for characterizing renal cell carcinoma. Clin Proteomics 2020;17:28.

Chinello C, L'Imperio V, Stella M, Smith AJ, Bovo G, Grasso A, et al. The proteomic landscape of renal tumors. Expert Review of Proteomics. 2016;13(12):1103–20. https://doi.org/10.1080/14789450.2016.1248415.CrossRefPubMed

Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883–92. https://doi.org/10.1056/NEJMoa1113205.CrossRefPubMedPubMedCentral

Title: Advancing the diagnosis and classification of renal cell carcinomas
Author: Joseph A. Rothwell
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Kidney Cancer
Kidney Cancer
Renal Cancer
Kidney Cancer
Published in: BMC Medicine / Issue 1/2021
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-021-02105-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Advancing the diagnosis and classification of renal cell carcinomas

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Development of a predictive model for integrated medical and long-term care resource consumption based on health behaviour: application of healthcare big data of patients with circulatory diseases

Adult retrospective report of child abuse and prospective indicators of childhood harm: a population birth cohort study

A phenome-wide association study of genetically mimicked statins

Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack

Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases

Temporal trends in cause-specific mortality among individuals with newly diagnosed atrial fibrillation in the Framingham Heart Study